Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TAX PROVISION
Tax Provision HALO - Halozyme Therapeutics, Inc.
66.7 M
LAST VALUE
55.97%
2 YEAR CAGR
162.35%
5 YEAR CAGR
41.68%
10 YEAR CAGR